newsfilter
← Latest News
GlobeNewswire·

Imara to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference

BOSTON, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Imara Inc. (NASDAQ:IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat subjects suffering from rare inherited genetic disorders of hemoglobi